Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Asset Utilization Ratio (2016 - 2025)

Corcept Therapeutics' Asset Utilization Ratio history spans 10 years, with the latest figure at 0.92 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 10.39% year-over-year to 0.92; the TTM value through Dec 2025 reached 0.92, up 10.39%, while the annual FY2025 figure was 0.91, 1.67% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.92 at Corcept Therapeutics, up from 0.91 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.92 in Q4 2025 and bottomed at 0.61 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.8 (2023), against an average of 0.77.
  • The largest annual shift saw Asset Utilization Ratio decreased 22.52% in 2021 before it soared 40.93% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.73 in 2021, then dropped by 0.77% to 0.72 in 2022, then increased by 10.27% to 0.79 in 2023, then rose by 4.69% to 0.83 in 2024, then increased by 10.39% to 0.92 in 2025.
  • Per Business Quant, the three most recent readings for CORT's Asset Utilization Ratio are 0.92 (Q4 2025), 0.91 (Q3 2025), and 0.87 (Q2 2025).